Raja Shahzad G
Department of Cardiac Surgery, Royal Hospital for Sick Children, Glasgow, United Kingdom.
Ann Thorac Surg. 2006 Mar;81(3):1162-71. doi: 10.1016/j.athoracsur.2005.08.002.
The treatment of patients with coronary artery disease continues to evolve. Recent, exciting data on the use of drug-eluting stents in diseased coronary vessels has generated immense enthusiasm within the interventional community leading to claims that "drug-eluting stents will put bypass surgeons out of business." However, despite promising short-term and midterm outcomes of this revolutionary new technology, valid concerns regarding long-term safety and efficacy of drug-eluting stents persist. This review article evaluates current status of drug-eluting stents with special emphasis on real and potential drawbacks of this emerging percutaneous coronary interventional modality and its impact on the practice of coronary artery bypass surgery.
冠心病患者的治疗方法不断发展。近期，有关在病变冠状动脉血管中使用药物洗脱支架的令人振奋的数据在介入治疗领域引发了极大的热情，有人宣称“药物洗脱支架将使心脏搭桥外科医生失业”。然而，尽管这项革命性新技术在短期和中期取得了令人鼓舞的成果，但对于药物洗脱支架的长期安全性和有效性仍存在合理担忧。这篇综述文章评估了药物洗脱支架的现状，特别强调了这种新兴经皮冠状动脉介入治疗方式的实际和潜在缺点及其对冠状动脉搭桥手术实践的影响。
Zotero 插件